Abstract
An inhibitor "fingerprinting' technique was used to test 120 group B and 50 group C streptococcus strains for production of inhibitory activity. The incidence of inhibitor production was low. Five of 70 group B streptococci of animal origin and one of 50 from human sources consistently produced inhibitory activity. Six of 20 animal strains and three of 30 human strains of group C streptococci were inhibitor producers. These included two Streptococcus dysgalactiae, three S. equisimilis and four S. zooepidemicus. The temperature of incubation and species of origin of the blood used in the culture medium were critical determinants of inhibitor production. Investigation of inhibitors for their spectrum of activity, heat stability, sensitivity to trypsin, dialysability and mode of action indicated that five of the group B and seven of the group C streptococci produced inhibitors that had bacteriocin-line properties. Three bovine strains of group B streptococci produced very similar inhibitory activity. A greater variety of bacteriocin-like substances was detected in the group C streptococcus strains. Two of the S. zooepidemicus strains were each found to produce more than one inhibitory substance.
Full text
PDF











Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Duca E., Teodorovici G., Radu C., Vî A., Talaşman-Niculescu P., Bernescu E., Feldi C., Roşca V. A new nephritogenic streptococcus. J Hyg (Lond) 1969 Dec;67(4):691–698. doi: 10.1017/s0022172400042145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EL GHOROURY A. A. Comparative studies of group "B" streptococci of human and bovine origin. I. Cultural and biochemical characters. Am J Public Health Nations Health. 1950 Oct;40(10):1273–1277. doi: 10.2105/ajph.40.10.1273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- EL GHOROURY A. A. Comparative studies of group "B" streptococci of human and bovine origin. II. Serological characters. Am J Public Health Nations Health. 1950 Oct;40(10):1278–1284. doi: 10.2105/ajph.40.10.1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Haug R. H., Gudding R., Bakken G. Serotyping and bacteriophage typing of human and bovine group-B streptococci. J Med Microbiol. 1981 Nov;14(4):479–482. doi: 10.1099/00222615-14-4-479. [DOI] [PubMed] [Google Scholar]
- Higgs T. M., Neave F. K., Bramley A. J. Differences in intramammary pathogenicity of four strains of Streptococcus dysgalactiae. J Med Microbiol. 1980 Aug;13(3):393–399. doi: 10.1099/00222615-13-3-393. [DOI] [PubMed] [Google Scholar]
- Hsu C., Wiseman G. M. Antibacterial substances from staphylococci. Can J Microbiol. 1967 Aug;13(8):947–955. doi: 10.1139/m67-127. [DOI] [PubMed] [Google Scholar]
- Jelínkoá J. Group B streptococci in the human population. Curr Top Microbiol Immunol. 1977;76:127–165. [PubMed] [Google Scholar]
- Johnson D. W., Tagg J. R., Wannamaker L. W. Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol. 1979 Nov;12(4):413–427. doi: 10.1099/00222615-12-4-413. [DOI] [PubMed] [Google Scholar]
- Krämer J., Brandis H. Charakterisierung eines Streptococcus agalactiae-Bacteriocins. Zentralbl Bakteriol Orig A. 1972 Mar;219(3):290–301. [PubMed] [Google Scholar]
- Noble W. C., Lloyd D. H., Appiah S. N. Inhibition of Dermatophilus congolensis infection in a mouse model by antibiotic-producing staphylococci. Br J Exp Pathol. 1980 Dec;61(6):644–647. [PMC free article] [PubMed] [Google Scholar]
- Parker M. T. Neonatal streptococcal infections. Postgrad Med J. 1977 Oct;53(624):598–606. doi: 10.1136/pgmj.53.624.598. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross P. W. Ecology of group B streptococci. Soc Appl Bacteriol Symp Ser. 1978;7:127–142. [PubMed] [Google Scholar]
- Stamm A. M., Cobbs C. G. Group C streptococcal pneumonia: report of a fatal case and review of the literature. Rev Infect Dis. 1980 Nov-Dec;2(6):889–898. doi: 10.1093/clinids/2.6.889. [DOI] [PubMed] [Google Scholar]
- Stringer J. The development of a phage-typing system for group-B streptococci. J Med Microbiol. 1980 Feb;13(1):133–143. doi: 10.1099/00222615-13-1-133. [DOI] [PubMed] [Google Scholar]
- Tagg J. R., Bannister L. V. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol. 1979 Nov;12(4):397–411. doi: 10.1099/00222615-12-4-397. [DOI] [PubMed] [Google Scholar]
- Tagg J. R., Dajani A. S., Wannamaker L. W. Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother. 1975 Jun;7(6):764–772. doi: 10.1128/aac.7.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tagg J. R., Dajani A. S., Wannamaker L. W. Bacteriocins of gram-positive bacteria. Bacteriol Rev. 1976 Sep;40(3):722–756. doi: 10.1128/br.40.3.722-756.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tzannetis S., Poulaki-Tsontou A., Papavassiliou J. Bacteriocine production in group B streptococci. Pathol Microbiol (Basel) 1974;41(1):51–57. doi: 10.1159/000162563. [DOI] [PubMed] [Google Scholar]
- Wilkinson H. W., Moody M. D. Serological relationships of type I antigens of group B streptococci. J Bacteriol. 1969 Feb;97(2):629–634. doi: 10.1128/jb.97.2.629-634.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilson C. D., Salt G. F. Streptococci in animal disease. Soc Appl Bacteriol Symp Ser. 1978;7:143–156. [PubMed] [Google Scholar]
